Health Condition 1: null- 1)Patients having aversion for Snehapana due to smell, oilyness, quantity and taste of sneha.
Conditions
Interventions
Intervention1: Group A - Anuvasan Basti of Murchit Tila Taila 120 ml and Saindhava 500 mg. Difference from Group B is that here we are giving dose 120 ml from first day to last day, therefore on the f
Sponsors
BVDU College of Ayurved
BVMFS Ayurved Hospital
Eligibility
Inclusion criteria
Inclusion criteria: Patients Arha for Vaman and Virechan
Exclusion criteria
Exclusion criteria: 1)Patients below age of 16 and above 70 years, 2)Patients Anarha for Vaman and Virechan and 3) Patients Anarha for Anuvasan Basti i.e. with local pathology of like Arsha, Bhagandhar.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Vatanuloman, Asamhat Varchs, Twak Snigdhata and KlamaTimepoint: Within 3 days to 7 days from starting Anuvasan Basti | — |
Secondary
| Measure | Time frame |
|---|---|
| Observed symptoms of samyak vaman and samyak virechan after administration of vaman and virechan. Symptoms of samyak vaman and virechan are Maniki, Vaigiki, Laingiki and AntikiTimepoint: At the time of vaman after one day gap from Anuvasan Basti and at the time of virechan after two day gap from Anuvasan Basti | — |
Countries
India
Contacts
Public ContactDr Surendra M Vedpathak
BVDU, College of Ayurved
Outcome results
None listed